Dr. Kirtikumar L. Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Kirtikumar L. Mehta, a promoter of Corona Remedies Limited, has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and persons acting in concert to disclose any encumbrance (such as pledging or invocation) on their shares in the company. The announcement does not specify whether the disclosure relates to creation, modification, release, or invocation of a pledge, or provide any details on the number of shares or percentage involved.
By itself, the announcement is procedural and does not indicate a change in promoter ownership. Shareholders should look for a follow-up filing with the actual encumbrance details to understand whether any pledge was created, released, or invoked, which could affect stock price sentiment.